Emergent BioSolutions (EBS) is up 11.8%, or 55c to $5.21.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions rises 9.0%
- Emergent BioSolutions announces $50M stock repurchase program
- Emergent Biosolutions’ Strategic Investments and Divestitures Justify Buy Rating
- Hikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal spray
- Emergent BioSolutions announces $27M in incremental sales
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue